ÂÜÀòÂÒÂ×

Arnoud Klokke is a Senior Associate at the BioInnovation Institute, where Arnoud focuses on early-stage biotech investments. Arnoud is also a Board Observer at Cymab and XY Therapeutics, and previously held the same position at Sevenless Therapeutics. Arnoud has experience as a Healthcare Investment Analyst at INKEF Capital and has worked in strategy and innovation at Merck Group. Arnoud participated in the Avicenna Excellence Program and has a background in Bio-Pharmaceutical Sciences and Business Administration from Leiden University.